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Controllable and switchable drug delivery of
ibuprofen from temperature responsive
composite nanofibers
Toan Tran, Mariana Hernandez, Dhruvil Patel, Elena Burns, Vanessa Peterman and Ji Wu*

Abstract
Composited electrospun nanofibers made of temperature-responsive poly(N-isopropylacrylamide) (pNIPAM) and
biodegradable poly (ε-caprolactone) (PCL) can be utilized for ‘on-demand’ and controlled drug release of ibuprofen
without burst effect for potential pharmaceutical applications. Three types of nanofibers, PCL, pNIPAM and pNIPAM/
PCL composite NFs containing ibuprofen were fabricated using electrospinning techniques. Ibuprofen release rates
from PCL NFs are not affected by the temperature in the range of 22–34°C (less than 10%). In contrast, the ibuprofen
release rates from pNIPAM NFs are very sensitive to the change in temperature, which is five times higher at 22°C
compared to 34°C. However, there is a serious burst effect at 22°C. Compared to other two types of NFs, pNIPAM/PCL
composite NFs prepared demonstrated a variable and controlled release at both room and higher temperature, due to
the extra protection from the hydrophobic poly (ε-caprolactone). The rate at 22°C is 75% faster compared to that at
34°C. This kind of composite design can provide a novel approach to suppress the burst effect in drug delivery systems
for potential pharmaceutical applications.
Keywords: Poly (ε-caprolactone); Poly(N-isopropylacrylamide); Nanofibers; Ibuprofen; Controlled release;
Temperature-responsive

1 Background
Currently, drug delivery systems are playing an important role in the fields of medical and pharmaceutical sciences [1]. A sustained and controlled release of drug
molecules is critically important to tissue engineering
and effective treatment of many diseases, ranging from
arthritis to cancer therapies [2,3]. In the past decade,
advanced nanotechnology and nanoscience have been
extensively applied to the fabrication of smart materials
which can controllably release drug molecules [4-7].
Despite the positive aspects of using nanomedicine there
are still quite a few challenges to overcome. A common
problem in drug delivery system is known as burst
effect, which is most likely due to the rapid release of
surface-associated drug molecules [8]. Another challenge
is to realize a programmable drug delivery with variable
dosing rates [9].
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Statesboro, GA, USA

Modern electrospinning technology allows for drug
delivery to be well controlled by tuning spinning parameters and materials. The cost, diameter, composition and
structure of electrospun nanofibers can be facilely varied
to regulate the drug delivery rates and kinetics. Poly (εcaprolactone) (PCL) is one of those biocompatible and
biodegradable polymers approved by US Food and Drug
Administration (FDA) for use in many biomedical devices [10]. PCL has been electrospun into nanofibers for
tissue engineering and drug delivery applications due to
its high porosity, interconnected pores and high surface
area-to-volume ratio [10,11]. However, dosing rates can’t
be varied under external stimulus. Poly(N-isopropylacrylamide) (pNIPAM) is a quite interesting biocompatible
thermo-responsive polymer [12]. When heated above 32°C
(its lower critical solution temperature, LCST), pNIPAM
undergoes a reversible phase transition from hydrophilic to
hydrophobic, losing ~90% of its volume, resulting in the
change of drug release rates [13]. Topical administration of
levothyroxine using poly vinyl alcohol (PVA) and pNIPAM
composite nanofibers were investigated by Azarbayjani
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et al. But it was found that there were serious burst effects
at both 25°C and 37°C due to the high water permeability of hydrophilic PVA [14]. Electrospun nanofibers
transdermal patches showed great capability for wound
healing because they can efficiently absorb exudates due
to extremely large surface area. [15,16] Most recently,
antibiotic ciprofloxacin loaded hydrophilic biodegradable
poly vinyl alcohol electrospun nanofibers have been
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successfully applied to in vivo wound healing treatment to
prevent infections [17].
In this report, electrospun nanofibers made of temperature responsive pNIPAM and hydrophobic PCL polymers were used for controllable and variable ibuprofen
(IP) release at both room temperature (22°C) and the
temperature above its lower critical solution temperature
(LCST) without any burst effects. These nanofibers can

Figure 1 Experimental design a) basic single nozzle electro-spinning setup; b) dual nozzle electro-spinning setup; c) cartoon diagram
to indicate the mechanism of reduced burst effects from pNIPAM/IP/PCL composite NFs.
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Figure 2 Scanning electron spectroscopy images of three types of NFs, a) PCL/IP, b) pNIPAM/IP and c) pNIPAM/IP/PCL composite NFs and
their corresponding histograms in NF diameter distribution d), e) and f), respectively. Scale bars for (a), (b) and (c) are 10, 1 and 1 μm, respectively.
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2 Methods
2.1 Materials

PCL with an average Mn of 45,000 and pNIPAM with
an average Mn of 19,000-30,000 were purchased from
Sigma-Aldrich. Ibuprofen with a purity >99.0% was
obtained from ACROS Organic. Ethanol and acetone
with purity higher than 99.5% were purchased from EMD
Millipore. Acetonitrile used for HPLC analysis was purchased from EMD Millipore also.
2.2 Fabrication of nanofibers

Three types of nanofibers (NFs) were fabricated using a
homebuilt electrospinning setup, including PCL/IP, pNIPAM/IP and pNIPAM/IP/PCL composite NFs. The schematic of electrospinning setup, working parameters and
detailed experimental conditions are shown in Figure 1.
The electrospinning working parameters were as follows:
applied voltage was direct current (DC) 25 kV (Spellman
P/N230-30R); distance between the syringe needle (16
gauge, Air-Tite Products Co.) containing the solution
and the grounding collector (aluminum foil) was 10 cm;
and pumping rate of syringe was 4 ml/hr. The syringe
pump was purchased from New Era Pump Systems Inc.
(NE-1000). Fabrication of PCL/IP NFs: First, 50 mg IP and
1.0 g PCL pellets were dissolved in 10 mL acetone under
magnetic stirring and sonication. Then the solution was
electrospun into PCL/IP NFs using a single nozzle spinet.
Fabrication of pNIPAM/IP NFs: 50 mg IP and 1.0 g pNIPAM powders were dissolved in 5.0 mL ethanol under
magnetic stirring. Then the solution was used to fabricate
pNIPAM/IP NFs using a single nozzle spinet. Fabrication
of pNIPAM/IP/PCL composite NFs: 50 mg IP and
1.0 g pNIPAM powders were dissolved in 5.0 mL ethanol
under magnetic stirring and used as the solution for
the core needle. 0.6 g PCL pellets were dissolved in
10 mL acetone under magnetic stirring and sonication, and used as the solution for the shell needle. A
double spinet was used for the electrospinning, whose
inner and outer needle sizes were 21 and 16 gauges, respectively. The flow rates of both core and shell needles
were 4 mL hr−1.

in the range of 4000 to 650 cm−1 at Georgia Southern
University.
2.4 Drug diffusion studies

All ibuprofen studies involving these three types of NFs
were carried out using a 5 mL PermeGear Franz cell
with a 10 mm diameter orifice for sampling. ~20 ± 1 mg
NFs were wetted and suspended in the receptor chamber
containing 4.0 mL of deionized water and a magnetic
stirring bar. It was calculated that there were 4.8, 4.8
and 3.7 μmol of ibuprofen in PCL/IP, pNIPAM/IP and
pNIPAM/IP/PCL fibers, respectively. 1 mL solution was
pipetted from the receiver chamber per hour and stored
into 1.8 mL amber glass vials for HPLC analysis. The
chamber was back-filled with 1.0 mL deionized water
after each sampling. All drug release profiles were averaged from triple measurements.
2.5 HPLC measurements and data analysis

All ibuprofen samples were analyzed by a Shimadzu
LCAT High Performance Liquid Chromatography (HPLC)
consisting of a SIL-20AHT autosampler, a LC-20AT HPLC
pump, a SPD-20A dual UV/Vis absorbance detector set at
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2.3 Characterization of nanofibers

The prepared samples were characterized using a Field
Emission Electron Microscopy (JEOL JSM-7600 F) at
Georgia Southern University for morphology examinations.
Fourier-Transform Infrared (FTIR) spectra of nanofiber samples were recorded in the attenuated total reflection (ATR) mode using an IR spectrophotometer
(Thermo-Nicolet AVATAR 370 FT-IR Spectrometer)
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be applied to transdermal drug delivery that can significantly enhance the efficacy of drug addiction and abuse
treatments [9].
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Figure 3 Frourier transform Infrared spectra of IP and three
types of electrospun nanofibers, ase well as pure ibuprofen.
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a wavelength of 254 nm and utilizing LabSolutions software. Thermo Scientific HyPURITY C18 reversed-phase
5 μm column (250 mm × 4 mm; L × I.D.) was used for the
separation. The mobile phase consisted of 0.1 wt% H3PO4
aqueous solution:acetonitrile (55:45) and flow rate of
1.0 mL/min. Calibration plots were prepared using IP
standards with concentrations over a range of 20–100 μg/
ml. The correlation coefficient (r2) obtained was ≥0.99 for
standard curves. The cumulative quantity of drug collected in the receiver compartment was plotted as a function of time. This method was adapted from a literature
reported method [18]. The lower limit of quantification
(LLOQ) was 2 μg/ml.

3 Results and discussion
The average diameter of PCL/IP NFs was ~1.7 μm with
a wide distribution from 500 nm to 3 μm as shown in
Figure 2a and d. If the concentration of PCL solution
was reduced from 10% to 6% (w/v), the diameters of
PCL/ibuprofen fibers can be significantly reduced to
below 300 nm on average. But there were both fibers
and beads, thus making the interpretation of diffusion
data very difficult. Figure 2b and e shows that the diameters of pNIPAM/IP nanofibers were in the range of 100–
900 nm with an average of 470 nm. Compared to PCL
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NFs, the standard deviation in the diameters for pNIPAM
NFs was much smaller. In the case of pNIPAM/IP/PCL
composite nanofibers, the average diameter and diameter
distribution were quite similar to those of pure pNIPAM
NFs (Figure 2c and f). Noteworthy, no apparent drug particles were observed on the surface of these NFs, thus
benefiting a reduced burst effect associated with surface
drug molecules.
These NFs were further characterized using Fourier
transform infrared (FTIR) spectroscopy (Figure 3). The
PCL/IP FTIR spectrum shows there are PCL finger
prints peaks at 2948 and 1728 and 1190 cm−1, which can
be assigned to the asymmetric C-H stretching, carbonyl
stretching and C–O stretching, respectively [19]. In the
FTIR spectrum of PNIPAM/IP nanofibers, characteristic
peaks of pNIPAM located at 1650 and 1550 cm−1 can be
assigned to amide carbonyl stretching and amide N-H
bending, respectively [20]. In the case of pNIPAM/IP/PCL
composited NFs, finger prints of both pNIPAM and
PCL can be clearly seen at 1190, 1550, 1650, 1728
and 2946 cm−1. The IP peaks can’t be clearly observed
might be due to its low weight percentage (5 wt%).
The release rates of ibuprofen from three types of NFs
were investigated in pH 7.4 deionized water at 22°C and
34°C (Figure 4 and Table 1). It is seen that 1 μmol of

Figure 4 Ibuprofen release profiles from a) pNIPAM NFs containing 50 mg Ibuprofen/g NFs; b) PCL NFs containing 50 mg Ibuprofen/g
NFs; c) pNIPAM and PCL composite NFs containing 50 mg Ibuprofen/g pNIPAM NFs. (*standard deviation bars were obtained from the
measurements of triple diffusion studies. The level of significance was set at a p value of less than 0.05).
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Table 1 Average cumulative amount of IP released from three types of NFs at 22 and 34°C
Cumulative amount
of IP released at 1 hr

Cumulative amount
of IP released at 2 hr

Cumulative amount
of IP released at 3 hr

Cumulative amount
of IP released at 4 hr

pNIPAM 22°C

1.13

1.17

1.23

1.30

pNIPAM 34°C

0.37

0.57

0.69

0.80

PCL 22°C

0.78

1.05

1.30

1.41

PCL 34°C

0.90

1.17

1.44

1.67

pNIPAM/PCL composite NFs 22°C

0.36

0.62

0.78

0.93

pNIPAM/PCL composite NFs 34°C

0.26

0.37

0.45

0.53

ibuprofen was quickly released from pNIPAM/IP NFs in
the first one hour at 22°C, and then the rest was released
at a much slower rate, 0.05 μmol hr−1. Totally, 24% IP
was released in four hours. In contrast, IP was released
at a more controllable mode when the temperature was
increased to 34°C. The average release rate was ~
0.2 μmol hr−1 and ~ 0.4 μmol IP was released in the first
one hour. Only 17% IP was released in 4 hrs. This
phenomenon can be explained by the high water solubility of pNIPAM when the temperature was below its
LCST (32°C), leading to the fast IP release from the
polymeric matrix. However, pNIPAM becomes much
hydrophobic when temperature was above its LCST.
Thus pNIPAM functions like a drug depot to prohibit
the fast release of hydrophobic IP molecules, resulting in
the relatively more controllable release mode. For PCL/
IP NFs, ~15% IP was released in the first 1 hr at 22°C
and 34°C and there was less than 10% change in devliery
rates for both temperatures. On average, 34% IP was released in 4 hrs. In the case of composite pNIPAM/IP/
PCL NFs, the diffusion rates at both 22°C and 34°C were
quite linear and well controlled without burst effects.
The controlled release was due to the presence of PCL
barrier that can provide extra buffer zone to reduce
burst effect, especially at lower temperature (below the
LCST of pNIPAM). Compared to the IP release rate at
34°C, the average IP release rate from this composite NF
was 75% faster at 22°C. Similiarly, it is because pNIPAM
was quite hydrophilic at room temperature. So water
molecules can diffuse through the PCL barrier and carry
out IP molecules more quickly. At high temperature,
both PCL and pNIPAM were hydrophobic, thus leading
to a reduced release rate of hydrophobic IP. On average,
13% and 25% IP were released from pNIPAM and PCL
composite NFs at 34 and 22°C, respectively.

4 Conclusions
Three types of polymeric nanofibers were fabricated
using electrospinning method for drug delivery studies.
Temperature has negligible effects on the IP diffusion
rates from PCL/IP NFs. For pNIPAM/IP NFs, there is a
significant burst effect at 22°C; whereas both diffusion

rate and burst effect are dramatically depressed at a
higher temperature. For pNIPAM/IP/PCL composite NFs,
burst effect was significantly reduced for both 22°C and
34°C. The diffusion rate is higher at 22°C compared to
that at 34°C by 75%. It can be naturally envisioned that
such kind of controllable and switchable delivery systems
could easily find many practical applications in both
pharmaceutical and medical sciences.
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